Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Troponin T | 6 | 2017 | 98 | 2.080 |
Why?
|
| Muscle, Skeletal | 13 | 2018 | 575 | 1.910 |
Why?
|
| Aging | 7 | 2017 | 1010 | 1.290 |
Why?
|
| Calcium Channels, L-Type | 3 | 2016 | 46 | 1.010 |
Why?
|
| MicroRNAs | 3 | 2017 | 197 | 0.910 |
Why?
|
| Muscle Fibers, Fast-Twitch | 3 | 2017 | 30 | 0.650 |
Why?
|
| Cell Nucleus | 4 | 2016 | 119 | 0.610 |
Why?
|
| Calpain | 2 | 2017 | 14 | 0.610 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 526 | 0.540 |
Why?
|
| Exercise Therapy | 2 | 2017 | 283 | 0.520 |
Why?
|
| Muscle Denervation | 1 | 2017 | 31 | 0.510 |
Why?
|
| Gait | 1 | 2017 | 134 | 0.480 |
Why?
|
| Excitation Contraction Coupling | 1 | 2015 | 8 | 0.450 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2015 | 115 | 0.450 |
Why?
|
| Mice | 13 | 2018 | 2720 | 0.440 |
Why?
|
| Calcium Channels | 1 | 2015 | 63 | 0.440 |
Why?
|
| Troponin | 1 | 2015 | 114 | 0.420 |
Why?
|
| Resistance Training | 1 | 2015 | 84 | 0.410 |
Why?
|
| Apoptosis | 2 | 2013 | 400 | 0.410 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 58 | 0.400 |
Why?
|
| Knee Joint | 1 | 2015 | 151 | 0.400 |
Why?
|
| Pericytes | 4 | 2014 | 32 | 0.390 |
Why?
|
| Muscle Cells | 1 | 2013 | 7 | 0.390 |
Why?
|
| Cell Line | 4 | 2016 | 476 | 0.390 |
Why?
|
| Animals | 18 | 2018 | 8579 | 0.380 |
Why?
|
| Exercise Tolerance | 1 | 2013 | 140 | 0.370 |
Why?
|
| RNA, Messenger | 1 | 2013 | 545 | 0.360 |
Why?
|
| Obesity | 1 | 2017 | 1246 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 7 | 2016 | 842 | 0.300 |
Why?
|
| Laryngeal Muscles | 3 | 2014 | 17 | 0.280 |
Why?
|
| Neuromuscular Junction | 3 | 2018 | 76 | 0.250 |
Why?
|
| Sulfonamides | 2 | 2017 | 86 | 0.240 |
Why?
|
| Muscle Contraction | 2 | 2017 | 183 | 0.220 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 152 | 0.220 |
Why?
|
| Acute Lung Injury | 2 | 2015 | 37 | 0.210 |
Why?
|
| Muscular Atrophy | 4 | 2018 | 77 | 0.180 |
Why?
|
| Flow Cytometry | 2 | 2013 | 198 | 0.180 |
Why?
|
| Male | 9 | 2017 | 20740 | 0.170 |
Why?
|
| Antigens | 4 | 2014 | 36 | 0.170 |
Why?
|
| Proteoglycans | 4 | 2014 | 37 | 0.170 |
Why?
|
| Exercise | 2 | 2017 | 701 | 0.160 |
Why?
|
| Synaptic Transmission | 2 | 2018 | 125 | 0.150 |
Why?
|
| Female | 7 | 2017 | 21532 | 0.150 |
Why?
|
| Receptors, Cholinergic | 1 | 2018 | 26 | 0.140 |
Why?
|
| Physical Conditioning, Animal | 2 | 2017 | 36 | 0.140 |
Why?
|
| Sympathetic Nervous System | 1 | 2018 | 34 | 0.140 |
Why?
|
| Muscle Fibers, Slow-Twitch | 2 | 2016 | 20 | 0.140 |
Why?
|
| Acetylcholine | 1 | 2018 | 69 | 0.140 |
Why?
|
| Wasting Syndrome | 2 | 2015 | 14 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 216 | 0.140 |
Why?
|
| Cell Differentiation | 3 | 2015 | 485 | 0.130 |
Why?
|
| Aged | 3 | 2017 | 11022 | 0.130 |
Why?
|
| Gene Expression | 3 | 2017 | 363 | 0.130 |
Why?
|
| Protein Phosphatase 1 | 1 | 2017 | 5 | 0.130 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2017 | 7 | 0.130 |
Why?
|
| Lipolysis | 1 | 2017 | 18 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2017 | 9 | 0.130 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2017 | 13 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 43 | 0.130 |
Why?
|
| Muscle Proteins | 2 | 2015 | 69 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 103 | 0.130 |
Why?
|
| Humans | 8 | 2017 | 34562 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 4157 | 0.120 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 19 | 0.120 |
Why?
|
| Muscle Fatigue | 1 | 2016 | 13 | 0.120 |
Why?
|
| Isometric Contraction | 1 | 2016 | 28 | 0.120 |
Why?
|
| Protein Stability | 1 | 2016 | 27 | 0.120 |
Why?
|
| Action Potentials | 1 | 2017 | 220 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 81 | 0.120 |
Why?
|
| Mice, Transgenic | 5 | 2014 | 279 | 0.120 |
Why?
|
| Gene Library | 1 | 2015 | 8 | 0.110 |
Why?
|
| Protein Binding | 1 | 2016 | 255 | 0.110 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 10 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2015 | 34 | 0.110 |
Why?
|
| Myogenin | 1 | 2014 | 5 | 0.110 |
Why?
|
| Neutrophils | 1 | 2015 | 123 | 0.110 |
Why?
|
| RNA Splicing | 1 | 2013 | 9 | 0.100 |
Why?
|
| Myoblasts | 1 | 2014 | 42 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 73 | 0.100 |
Why?
|
| Muscle Strength | 1 | 2015 | 157 | 0.100 |
Why?
|
| Weight Loss | 1 | 2017 | 494 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 84 | 0.100 |
Why?
|
| Age Factors | 1 | 2017 | 1262 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 118 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 204 | 0.100 |
Why?
|
| Ischemia | 1 | 2014 | 119 | 0.100 |
Why?
|
| Adipogenesis | 1 | 2013 | 30 | 0.100 |
Why?
|
| Leucine Zippers | 1 | 2013 | 3 | 0.100 |
Why?
|
| Nuclear Localization Signals | 1 | 2013 | 4 | 0.100 |
Why?
|
| Annexin A5 | 1 | 2013 | 8 | 0.100 |
Why?
|
| Calcium | 1 | 2015 | 343 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 4 | 2014 | 72 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 66 | 0.100 |
Why?
|
| Body Composition | 1 | 2015 | 415 | 0.090 |
Why?
|
| Biopsy | 1 | 2013 | 273 | 0.090 |
Why?
|
| Levodopa | 1 | 2012 | 15 | 0.090 |
Why?
|
| Neuroglia | 1 | 2012 | 32 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2014 | 161 | 0.090 |
Why?
|
| Reflex | 1 | 2012 | 21 | 0.090 |
Why?
|
| Dopamine Agents | 1 | 2012 | 21 | 0.090 |
Why?
|
| Quadriceps Muscle | 1 | 2012 | 35 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 45 | 0.090 |
Why?
|
| Electroporation | 1 | 2011 | 15 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2011 | 57 | 0.090 |
Why?
|
| Extremities | 1 | 2012 | 55 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 99 | 0.090 |
Why?
|
| Myosin Heavy Chains | 1 | 2012 | 89 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2011 | 66 | 0.090 |
Why?
|
| Regeneration | 1 | 2013 | 179 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2014 | 889 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 3 | 2017 | 130 | 0.080 |
Why?
|
| Luminescent Proteins | 3 | 2014 | 27 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 649 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2367 | 0.070 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 122 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2014 | 296 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2013 | 71 | 0.050 |
Why?
|
| Intermediate Filament Proteins | 2 | 2012 | 11 | 0.050 |
Why?
|
| Time Factors | 2 | 2015 | 2353 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 1129 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2018 | 66 | 0.030 |
Why?
|
| Rats | 2 | 2012 | 1946 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2017 | 9 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 9 | 0.030 |
Why?
|
| Salivary Glands | 1 | 2017 | 14 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 30 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 145 | 0.030 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2015 | 9 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2015 | 20 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2015 | 27 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 781 | 0.030 |
Why?
|
| Chemokines | 1 | 2015 | 36 | 0.030 |
Why?
|
| Respiratory Distress Syndrome, Adult | 1 | 2015 | 51 | 0.030 |
Why?
|
| Chromatin | 1 | 2014 | 28 | 0.030 |
Why?
|
| Actins | 1 | 2014 | 56 | 0.030 |
Why?
|
| Vocal Cords | 1 | 2014 | 10 | 0.030 |
Why?
|
| Hindlimb | 1 | 2014 | 55 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 87 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2013 | 3 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 4 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2013 | 44 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 131 | 0.020 |
Why?
|
| Laryngeal Nerves | 1 | 2012 | 5 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 356 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 486 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 132 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2012 | 13 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 26 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 657 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 63 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 101 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 153 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 114 | 0.020 |
Why?
|
| Reaction Time | 1 | 2012 | 131 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2013 | 204 | 0.020 |
Why?
|
| Inflammation | 1 | 2015 | 557 | 0.020 |
Why?
|
| Proteomics | 1 | 2012 | 106 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 229 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3623 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 923 | 0.020 |
Why?
|